Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck cancer | Molecular Cancer | Full Text
Frontiers | HGF/c-Met Axis: The Advanced Development in Digestive System Cancer
cIRCR201-dPBD, a Novel Pyrrolobenzodiazepine Dimer-Containing Site-Specific Antibody–Drug Conjugate Targeting c-Met Overexpression Tumors | ACS Omega
Structural basis of the activation of c-MET receptor | Nature Communications
c-Met Archives - Network of Cancer Research
c-Met as a potential therapeutic target in triple negative breast cancer - ScienceDirect
Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities | Molecular Cancer | Full Text
Tyrosine Kinase Assay Kits | MBL Life Sience -ASIA-
Artificial human Met agonists based on macrocycle scaffolds | Nature Communications
Frontiers | Crosstalk Mechanisms Between HGF/c-Met Axis and ncRNAs in Malignancy
c-Met Monoclonal Antibody (3D4) (37-0100)
HGF/c-MET pathway in cancer: from molecular characterization to clinical evidence | Oncogene
c-Met as a potential therapeutic target in triple negative breast cancer - ScienceDirect
C-Met - wikidoc
Frontiers | The Function of the HGF/c-Met Axis in Hepatocellular Carcinoma
BMS-794833 | 99.84%(HPLC) | In Stock | c-Met inhibitor
What Is MET? - MET Crusaders
C-Met - Wikipedia
IJMS | Free Full-Text | HGF/c-MET Signaling in Melanocytes and Melanoma
Safety and Tolerability of c-MET Inhibitors in Cancer | SpringerLink
C-Met - Wikipedia
Frontiers | c-Met-integrin cooperation: Mechanisms, tumorigenic effects, and therapeutic relevance
C-Met - Wikipedia
Frontiers | Selective Inhibitor of the c-Met Receptor Tyrosine Kinase in Advanced Hepatocellular Carcinoma: No Beneficial Effect With the Use of Tivantinib?
